Electrophysiology and Arrhythmias

Science News

Impact of the COVID-19 Pandemic on Cardiovascular Science
Systems of Care for ST-Segment–Elevation Myocardial Infarction
Cerebrovascular Events in Patients with Centrifugal-Flow Left Ventricular Assist Devices: A Propensity Score Matched Analysis from the Intermacs Registry
Diagnosis and Management of Myocarditis in Children
Managing Atrial Fibrillation in Patients With Heart Failure and Reduced Ejection Fraction

Journals

Underrepresentation of Ethnic and Racial Minorities in Atrial Fibrillation Clinical Trials
Trends in the Use of Oral Anticoagulants and Associated Expenditures Among Medicaid Programs
Direct Oral Anticoagulant Adherence of Patients With Atrial Fibrillation Transitioned from Warfarin
Atrial Fibrillation in Patients With Cardiomyopathy: Prevalence and Clinical Outcomes From Real‐World Data
Ischemic ST‐Segment Depression Maximal in V1–V4 (Versus V5–V6) of Any Amplitude Is Specific for Occlusion Myocardial Infarction (Versus Nonocclusive Ischemia)

Continuing Education

Scientific Sessions attendees looking at a phone in front of giant Heart and Torch stature

Meet us in November in Boston or online from anywhere through our virtual platform for the global cardiovascular event of the year! Reconnect with colleagues, experience breakthrough cardiovascular basic, clinical and population science updates, and immerse yourself in innovative solutions designed to help you in your daily practice at the American Heart Association’s Scientific Sessions 2021.

  • Enjoy instant access to leaders in the field and the latest discoveries in cardiovascular science and medicine.

  • Reconnect and collaborate with global thought leaders from over around the world.

  • Experience programming designed with your needs in mind with 27 programming communities.
  • CE and MOC credits available.

  • And more!

Don’t forget! AHA Professional Members receive the best rates for attending Scientific Sessions. Learn more about this and other benefits by becoming an AHA Professional Member.

The CLCD Council supports AHA objectives in clinical cardiology, promotes excellent clinical care, and fosters professional development and education for clinical cardiologists. Through council-sponsored symposia, panels, and scientific conferences, members can access and interpret new developments in the field and promote clinical cardiology to professional and lay audiences.


CRAVE Results

Gregory M. Marcus, MD, MAS explains the methodology and results of the CRAVE trial, designed to assess the acute affects of coffee consumption in ambulatory patients.

aMAZE Results

Mina Chung, MD, FHRS discusses the results of the aMAZE trial with principal investigator David J. Wilber, MD, FAHA, FACC, FHRS. The trial examined percutaneous alternatives to the MAZE procedure for persistent AF.

American Heart Association Professional Members

Enjoy instant benefits!

  • Free Online Access to AHA Scientific Journals
  • Affiliate with our 16 Scientific Councils
  • Discounts on Scientific Conference Registration and Online Courses